×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
HOWL – werewolf therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
HOWL
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/8
02:33 am
howl
Werewolf Therapeutics GAAP EPS of -$0.38 beats by $0.07 Nov. 08, 2024 2:25 AM ET By: Manshi Mamtora , CFA [Seeking Alpha]
Low
Report
Werewolf Therapeutics GAAP EPS of -$0.38 beats by $0.07 Nov. 08, 2024 2:25 AM ET By: Manshi Mamtora , CFA [Seeking Alpha]
11/7
09:02 am
howl
Werewolf Therapeutics Presents Preclinical and Clinical Data at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting
Medium
Report
Werewolf Therapeutics Presents Preclinical and Clinical Data at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting
11/7
09:00 am
howl
Werewolf Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
Medium
Report
Werewolf Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
10/31
08:00 am
howl
Werewolf Therapeutics Announces Promising New Development Candidate, WTX-921, a first-of-its-kind IL-10 INDUKINE™ Molecule for Inflammatory Diseases
Medium
Report
Werewolf Therapeutics Announces Promising New Development Candidate, WTX-921, a first-of-its-kind IL-10 INDUKINE™ Molecule for Inflammatory Diseases
10/4
09:00 am
howl
Werewolf Therapeutics to Present Posters at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting
Low
Report
Werewolf Therapeutics to Present Posters at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting
9/3
08:00 am
howl
Werewolf Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Medium
Report
Werewolf Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
04:05 pm
howl
Form SC 13G/A Werewolf Therapeutics, Filed by: PFM Health Sciences, LP
Medium
Report
Form SC 13G/A Werewolf Therapeutics, Filed by: PFM Health Sciences, LP
11/14
11:54 am
howl
Form SC 13G/A Werewolf Therapeutics, Filed by: BANK OF AMERICA CORP /DE/
Low
Report
Form SC 13G/A Werewolf Therapeutics, Filed by: BANK OF AMERICA CORP /DE/
11/13
04:31 pm
howl
Form SC 13G/A Werewolf Therapeutics, Filed by: Rubric Capital Management LP
Medium
Report
Form SC 13G/A Werewolf Therapeutics, Filed by: Rubric Capital Management LP
11/12
09:38 am
howl
Form SC 13G/A Werewolf Therapeutics, Filed by: Adage Capital Management, L.P.
Low
Report
Form SC 13G/A Werewolf Therapeutics, Filed by: Adage Capital Management, L.P.
11/12
09:25 am
howl
Form 8-K Werewolf Therapeutics, For: Nov 12
Low
Report
Form 8-K Werewolf Therapeutics, For: Nov 12
11/7
09:10 am
howl
Form 10-Q Werewolf Therapeutics, For: Sep 30
Medium
Report
Form 10-Q Werewolf Therapeutics, For: Sep 30
11/7
09:07 am
howl
Form 8-K Werewolf Therapeutics, For: Nov 07
Medium
Report
Form 8-K Werewolf Therapeutics, For: Nov 07
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: